Sort
53,477 grants matching “addiction”
The Impact of Design Characteristics on the Modification Potential of Electronic Nicotine Delivery Systems
$466,497Lyudmila Popova · Georgia State University · R01 · FY2020 · DA
Antibody-based Therapy for Methamphetamine Abuse
$466,495University Of Arkansas Med Scis Ltl Rock · R01 · FY2004 · DA
Computerized Screening for Comorbidity in Adolescents with Substance or Psychiatr
$466,468Kenneth A Kobak · Center For Psychological Consultation · R44 · FY2016 · MH
Functional Heterogeneity of Hypocretin Neurons
$466,427Luis De Lecea · Stanford University · R01 · FY2023 · MH
Organizational Capacity to Eliminate Outcome Disparities under Healthcare Reform
$466,421Erick Guerrero · University Of Southern California · R33 · FY2016 · DA
Neuroscience Training in Drug Abuse Research
$466,369Paul G Mermelstein · University Of Minnesota · T32 · FY2019 · DA
Hypothalamic Neuronal Activity During Insomnia Induced by Chronic Ethanol Exposure
$466,314Carlos A. Blanco-Centurion · Medical University Of South Carolina · R01 · FY2022 · AA
GABA-A receptor subtype mechanisms and the abuse-related effects of alcohol
$466,274Donna M. Platt · University Of Mississippi Med Ctr · R01 · FY2024 · AA
Integrative Genetics and Genomics Core
$466,236Vivek Philip · Jackson Laboratory · P50 · FY2025 · DA
Differential Roles of Prefrontal Cortical Interneurons in Drug Seeking after Withdrawal
$466,213Byungkook Lim · University Of California, San Diego · R01 · FY2025 · DA
Clinical Trials Network: New Mexico Node
$466,199University Of New Mexico · U10 · FY2004 · DA
Innovative Interventions for Smoking Cessation
$466,186Dorothy K Hatsukami · University Of Minnesota · R01 · FY2010 · DA
Novel roles for the circadian transcription factor NPAS2 and striatal dopamine D3 receptor signaling in diurnal fentanyl craving and relapse
$466,181Ryan W Logan · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · DA
Understanding the real-world impact of the use of three alternate nicotine-delivery products on combustible cigarette use
$466,163Megan E Piper · University Of Wisconsin-Madison · R01 · FY2021 · CA
Clinical Data Intelligence & Advanced Analytics to Reduce Drug Diversion across the Care Delivery Cycle and Drug Supply Chain in Health Systems
$466,155Tom Knight · Invistics Corporation · R44 · FY2017 · DA
Discovery of novel openers of the understudied human drug target Kir6.1
$466,125Timothy J Cardozo · New York University School Of Medicine · R21 · FY2022 · TR
Central glutamate signaling in postoperative pain regulation - Renewal
$466,122Jing Wang · New York University School Of Medicine · R01 · FY2020 · GM
Central glutamate signaling in postoperative pain regulation - Renewal
$466,122Jing Wang · New York University School Of Medicine · R01 · FY2022 · GM
Central glutamate signaling in postoperative pain regulation - Renewal
$466,122Jing Wang · New York University School Of Medicine · R01 · FY2021 · GM
CB-1 Antagonists for Cannabis Addiction
$466,102Jack Bergman · Mclean Hospital · R01 · FY2008 · DA
Administrative Core
$466,073Leslie Diane Leve · University Of Oregon · P50 · FY2020 · DA
Development of Natural Product Leads as Anticancer Therapeutics
$466,064John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
[18F] FPEB Studies of the mGluR5 Receptor and Methamphetamine Abuse
$466,055Robert Michael Kessler · University Of Alabama At Birmingham · R33 · FY2017 · DA
Substance Abuse Training Center in Public Health
$466,043Linda B Cottler · University Of Florida · T32 · FY2024 · DA
Rivastigmine and Huperzine A as Potential Treatments for Cocaine Addiction
$466,041Richard De La Garza · Baylor College Of Medicine · R01 · FY2011 · DA